Cosmetics Regulation

02009R1223-20250901 → 02009R1223-20260501

ANNEX II LIST OF SUBSTANCES PROHIBITED IN COSMETIC PRODUCTS OJ L 159, 29.6.1996, p. 1Modified INNM-name.OJ L 273, 10.10.2002, p. 1.for the individual ingredient see reference number 364 in Annex II.for the individual ingredient see reference number 413 in Annex II.From 23 … 14,526 unchanged words … salt [8] 1330-43-4 [8] 215-540-4 [8] Tetraboron disodium heptaoxide, hydrate [9] 12267-73-1 [9] 235-541-3 [9] Orthoboric acid, sodium salt [10] 13840-56-7 [10] 237-560-2 [10] Disodium tetraborate decahydrate; borax decahydrate [11] 1303-96-4 [11] 215-540-4 [11] Disodium tetraborate pentahydrate; borax pentahydrate [12] 12179-04-3 [12] 215-540-4 [12] 1397 Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] 13517-20-9 [1] 239-172-9 [1] Perboric acid, sodium salt, tetrahydrate [2] 37244-98-7 [2] 234-390-0 [2] Perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] 10486-00-7 [3] — [3] Sodium peroxoborate, hexahydrate [4] — [4] — [4] Sodium perborate [1] [5] 15120-21-5 [5] 239-172-9 [5] Sodium peroxometaborate; sodium peroxoborate [2] 15120-21-5 [1] 239-172-9 [1] 7632-04-4 [2] [6] 7632-04-4/10332-33-9/10486-00-7 [6] 231-556-4 [6] Perboric acid, sodium salt [7] 11138-47-9 [7] 234-390-0 [7] Perboric acid, sodium salt, monohydrate [8] 12040-72-1 [8] 234-390-0 [8] Perboric acid (HBO(O2)), sodium salt, monohydrate [9] 10332-33-9 [2] 10486-00-7[2] 231-556-4 [2] [9] — [9] Trimethyl borate 121-43-7 [10] 204-468-9 [10] 1398 Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] 13517-20-9 [1] 239-172-9 [1] Perboric acid, sodium salt, tetrahydrate [2] 37244-98-7 [2] 234-390-0 [2] Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3] 10486-00-7 [3] 231-556-4 [3] 1399 Perboric acid, sodium salt [1] 11138-47-9 … 2,747 unchanged words … Pentasodium Pentetate (INCI) 140-01-2 205-391-3 1722 Acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine 135410-20-7/ 160430-64-8 603-921-1/ 682-791-8 1723 Pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene 40487-42-1 254-938-2 1724 Bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 25057-89-0 246-585-8 1725 Styrene/Acrylates copolymer (nano) [INCI] Sodium Styrene/Acrylates copolymer (nano) [INCI] 9010-92-8 927-710-1 1726 Copper (nano) [INCI], Colloidal Copper (nano) [INCI] 7440-50-8 231-159-6 1727 Colloidal silver Silver (nano) [INCI] [1 nm < particle diameter ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm] 7440-22-4 231-131-3 1728 Gold (nano) [INCI], Colloidal Gold (nano) [INCI] [1] Gold Thioethylamino Hyaluronic Acid (nano) [INCI] [2] Acetyl heptapeptide-9 Colloidal gold (nano) [INCI] [3] 7440-57-5 [1] 1360157-34-1 [2] [3] 231-165-9 [1] [2] [3] 1729 Platinum (nano) [INCI], Colloidal Platinum (nano) [INCI] [1] Acetyl tetrapeptide-17 Colloidal Platinum (nano) [INCI] [2] 7440-06-4 [1] [2] 231-116-1 [1] [2] 1730 3-(4'-methylbenzylidene)-camphor; [INCI: 4-Methylbenzylidene Camphor] 36861-47-9/38102-62-4 253-242-6/- 1731 diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; INCI: Trimethylbenzoyl Diphenylphosphine Oxide 75980-60-8 278-355-8 1732 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol; tetrabromobisphenol-A 79-94-7 201-236-9 1733 transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 118712-89-3 405-060-5 1734 clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine 210880-92-5 433-460-1 1735 benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate 577705-90-9 479-100-5 1736 benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1) 75768-65-9 278-305-5 1737 reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1) - - 1738 reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (1:1) - - 1739 dimethyl propylphosphonate 18755-43-6 242-555-3 1740 dibutyltin maleate 78-04-6 201-077-5 1741 dibutyltin oxide 818-08-6 212-449-1 1742 reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3-epoxypropoxy)methyl)-2-hydroxymethyl butane - - 1743 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol; bisphenol AF 1478-61-1 216-036-7 1744 benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine 1861-40-1 217-465-2 1745 N,N-dimethyl-p-toluidine 99-97-8 202-805-4 1746 1,4-Benzenediamine, N,N’-mixed Ph and tolyl derivs. 68953-84-4 273-227-8 1747 4-nitrosomorpholine 59-89-2 - 1748 difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether 119446-68-3 - 1749 4-methylimidazole 822-36-6 212-497-3 1750 3,3'-dimethylbiphenyl-4,4'-diyl diisocyanate 91-97-4 202-112-7 1751 foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea 173159-57-4 -1752 Multi-walled Carbon Tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 μm and a length ≥ 5 μm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T — — 1753 reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol — — 1754 Acetone oxime 127-06-0 204-820-1 1755 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one 119344-86-4 438-340-0 1756 2,3-epoxypropyl neodecanoate 26761-45-5 247-979-2 1757 Benthiavalicarb-isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate 177406-68-7 — 1758 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate 2386-87-0 219-207-4 1759 Sodium 3-(allyloxy)-2-hydroxypropanesulphonate 52556-42-0 258-004-5 1760 1,4-dichloro-2-nitrobenzene 89-61-2 201-923-3 1761 Fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine 67306-00-7 — 1762 N,N’-methylenediacrylamide 110-26-9 203-750-9 1763 tert-butyl 2-ethylperoxyhexanoate 3006-82-4 221-110-7 1764 Trimethyl borate 121-43-7 204-468-9 1765 S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] 87392-12-9 — 1766 Pyraclostrobin (ISO); methyl N-(2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl) N-methoxy carbamate 175013-18-0 —

02009R1223-20250901 → 02009R1223-20260501

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX III LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 1.For use as a preservative, see Annex V, No. 5.Only if the concentration exceeds 0,05 %.These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 2.The quantity of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In cases of mixtures, the sum should not exceed the limits given in column g.The concentration of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In case of mixtures, the sum should not exceed the limits given in column g.For use as a preservative, see Annex V, No. 34.For use as a preservative, see Annex V, No 43.For use as a preservative, see Annex V, No. 54.For use as a preservative see Annex V, No 3.Solely for products which might be used for children under 3 years of age.For use as a preservative, see Annex V, No 9.For use as a preservative, see AnnexV, No 23.For use as a preservative, see Annex V, No 8.Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications (OJ L 255, 30.9.2005, p. 22).This limit applies to the substance and not to the finished cosmetic product.The sum of those substances used in combination should not exceed the limits given as Maximum concentration in ready for use preparation.The free base and salts of this hair colouring ingredient, unless prohibited under Annex II, are permitted for use.For use as a preservative, see Annex V, No 58.For use as a preservative, see Annex V, entry No 44.For other uses of potassium hydroxide, see Annex III, No 15d.For other uses of potassium hydroxide, see Annex III, No 15a.From 25 September 2018 cosmetic products containing peanut oil, extracts and derivatives and not complying with that restriction shall not be placed on the Union market. From 25 December 2018 cosmetic products containing peanut oil, extracts and derivatives and not complying with that restriction shall not be made available on the Union market.From 25 September 2018 cosmetic products containing hydrolyzed wheat proteins and not complying with that restriction shall not be placed on the Union market. From 25 December 2018 cosmetic products containing hydrolyzed wheat proteins and not complying with that restriction shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.For use as a preservative, see Annex V, entry 32.From 27 November 2019 cosmetic products containing 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one and not complying with those restrictions shall not be placed on the Union market. … 602 unchanged lines … Cuminum Cyminum Fruit Extract; Cuminum Cyminum Seed Oil; Cuminum Cyminum Seed Extract; Cuminum Cyminum Seed Powder 84775-51-9 283-881-6 (a) Leave-on products (a) 0,4 % of Cumin oil (b) Rinse-off products 157 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one Alpha-Damascone; cis-Rose ketone 1 43052-87-5/ 23726-94-5 -/ 245-845-8 (a) Oral products (b) Other products (b) 0,02 % (a) (b) Cuminum Cyminum Seed Powder 84775-51-9 283-881-6 (a) Leave-on products (a) 0,4 % of Cumin oil (b) Rinse-off products 157 1-(2,6,6-trimethyl-2- cyclohexen-1-yl)-2-buten-1-one Alpha-Damascone; 43052-87-5/ -/ (a) Oral products (b) 0,02 % (a) (b) The presence of the substance or substances shall be indicated as Rose Ketones in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products. trans-Rose ketone 1 24720-09-0 246-430-4 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)-2-buten-1-one Rose ketone 4 (Damascone) 23696-85-7 245-833-2 1-(2,6,6-Trimethyl-3-cyclohexen-1-yl)-2-buten-1-one Rose ketone 3 (delta-Damascone) 57378-68-4 260-709-8 0,001 % in leave-on products 0,01 % in rinse-off products. cis-Rose ketone 1 23726-94-5 245-845-8 (b) Other products trans-Rose ketone 1 24720-09-0 246-430-4 1-(2,6,6-Trimethyl cyclohexa-1,3-dien-1-yl)-2-buten-1-one Rose ketone 4 (Damascenone) 23696-85-7 245-833-2 1-(2,6,6-Trimethyl- 3-cyclohexen-1-yl)-2-buten-1- one Rose ketone 3 (delta-Damascone) 57378-68-4 260-709-8 trans-Rose ketone 3 71048-82-3 275-156-8 (Z)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one cis-Rose ketone 2 (Z)-1-(2,6,6- trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one cis-Rose ketone 2 (cis-beta-Damascone) 23726-92-3 245-843-7 (E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one trans-Rose ketone 2 (E)-1-(2,6,6- Trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one trans-Rose ketone 2 (trans-beta-Damascone) 23726-91-2 245-842-1 158 trans-Rose ketone-2; (E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one (trans-beta-Damascone) trans-Rose ketone-2 23726-91-2 245-842-1 (a) Oral products (b) Other products (b) 0,02 % 159 trans-Rose ketone-5; (E)-1-(2,4,4-Trimethyl-2-cyclohexen-1-yl)-2-buten-1-one (Isodamascone) trans-Rose ketone-5 39872-57-6 254-663-8 0,02 % 160 Rose ketone-4; 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)-2-buten-1-one (Damascenone) Rose ketone-4 23696-85-7 245-833-2 (a) Oral products (b) Other products (b) 0,02 % … 1,396 unchanged lines … 0,01 % in rinse-off products. Narcissus Pseudonarcissus Flower Extract 90064-27-0 290-088-9 Narcissus Jonquilla Extract Narcissus Tazetta Extract 90064-25-8 290-086-8 364 Pelargonium graveolens oil Pelargonium Graveolens Flower Oil 90082-51-2/ 8000-46-2 290-140-0/ - The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products. 365 Pogostemon cablin oil Pogostemon Cablin Oil 8014-09-3/ 84238-39-1 -/ 282-493-4 The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products. 366 Rosa damascena flower oil/extract; Rosa Damascena Flower Oil; Rosa Damascena Flower Extract 8007-01-0/ 364 Pelargonium graveolens oil Pelargonium Graveolens Oil Pelargonium Graveolens Flower Oil Pelargonium Graveolens Leaf Oil 90082-51-2/ 8000-46-2 290-140-0/ - The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products 365 Pogostemon cablin oil Pogostemon Cablin Oil Pogostemon Cablin Leaf Oil 8014-09-3/ 84238-39-1 -/ 282-493-4 The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products 366 Rosa damascena flower oil/extract; Rosa Damascena Flower Oil; Rosa Damascena Flower Extract 8007-01-0/ 90106-38-0/ -/ 290-260-3 The presence of the substance or substances shall be indicated as Rose Flower Oil/Extract in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds: 0,001 % in leave-on products … 38 unchanged lines … [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate Retinyl Palmitate 79-81-2 201-228-5 377 4-Hydroxyphenyl-alpha-D-glucopyranoside Alpha-Arbutin 84380-01-8 617-561-8 (a) Face cream (b) Body lotion (a) 2 % (b) 0,5 % Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level. 378 4-Hydroxyphenyl-beta-D-glucopyranoside Arbutin 497-76-7 207-850-3 Face cream 7 % Hydroquinone levels shall remain as low as possible in formulations containing Arbutin and shall not be higher than the unavoidable trace level. (b) 0,5 % Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level. 378 4-Hydroxyphenyl-beta-D-glucopyranoside Arbutin 497-76-7 207-850-3 Face cream 7 % Hydroquinone levels shall remain as low as possible in formulations containing Arbutin and shall not be higher than the unavoidable trace level. 379 Silver (powder) [100 nm < particle diameter < 1 mm] Silver 7440-22-4 231-131-3 (a) Toothpaste (b) Mouthwash For (a) and (b): 0,05 % 380 Hexyl 2-hydroxybenzoate Hexyl Salicylate 6259-76-3 228-408-6 (a) Hydroalcoholic-based fragrances (except hydroalcoholic-based fragrances intended for children below 3 years of age) (b) All rinse-off products (except shower gel/bath products, hand wash, hair conditioner and shampoo intended for children below 3 years of age) (c) All leave-on products (except hair conditioner, body lotion, face cream, hand cream, lipstick/lip balm and fragrance products intended for children below 3 years of age) (d) Toothpaste (e) Mouthwash (f) Shower gel/bath products, hand wash, shampoo, hair conditioner, body, face and hand (skin) care products, lipstick/lip balm and fragrance products intended for children below 3 years of age (a) 2 % (b) 0,5 % (c) 0,3 % (d) 0,001 % (e) 0,001 % (f) 0,1 % Not to be used in preparations for children under 3 years of age, with the exception of (d) Toothpaste and (f).

02009R1223-20250901 → 02009R1223-20260501

ANNEX IV LIST OF COLORANTS ALLOWED IN COSMETIC PRODUCTS Preamble Without prejudice to other provisions in this Regulation, a colorant shall include its salts and lakes and when a colorant is expressed as a specific salt, its other salts and lakes shall also … 1,914 unchanged words … Purity criteria as set out in Commission Directive 95/45/EC (E 172) 138 Ferric Ammonium Ferrocyanide 77510 Blue free from cyanide ions 139 Magnesium carbonate 77713 White 140 Ammonium manganese(3+) diphosphate 77742 Violet 141 Trimanganese bis (orthophosphate) 77745 Red 142 Silver (powder) [100 nm < particle diameter < 1 mm] 77820 7440-22-4 231-131-3 White Purity criteria as set out in Commission Directive 95/45/EC (E 174) (a) Lip products (b) Eye shadow For (a) and (b): 0,2 % 143 Titanium dioxide 77891 236-675-5 White Purity criteria as set out in Commission Directive 95/45/E (E 171) Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321 144 Zinc oxide 77947 1314-13-2 215-222-5 White Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. 145 Riboflavin Lactoflavin 201-507-1/204-988-6 Yellow Purity criteria as set out in Commission Directive 95/45/EC (E 101) 146 Caramel Caramel 232-435-9 Brown Purity criteria as set out in Commission Directive 95/45/EC (E 150a-d) 147 Paprika extract, Capsanthin, capsorubin Capsanthin, capsorubin 207-364-1/207-425-2 Orange Purity criteria as set out in Commission Directive 95/45/EC (E 160c) 148 Beetroot red Beetroot Red 7659-95-2 231-628-5 Red Purity criteria as set out in Commission Directive 95/45/EC (E 162) 149 Anthocyanins (Cyanidin, Peonidin Malvidin Delphinidin Petunidin Pelargonidin) Anthocyanins 528-58-5 134-01-0 528-53-0 643-84-5 134-04-3 208-438-6 205-125-6 211-403-8 208-437-0 — 205-127-7 Red Purity criteria as set out in Commission Directive 95/45/EC (E 163) 150 Aluminium, zinc, magnesium and calcium stearates Aluminum stearate Zinc stearate Magnesium stearate Calcium stearate 7047-84-9 557-05-1 557-04-0 216-472-8 230-325-5 209-151-9 209-150-3 216-472-8 White 151 Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide Bromothymol blue 76-59-5 200-971-2 Blue Rinse-off products 152 Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-,S,S-dioxide Bromocresol green 76-60-8 200-972-8 Green Rinse-off products 153 Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate Acid red 195 12220-24-5 — Red Not to be used in products applied on mucous membranes

02009R1223-20250901 → 02009R1223-20260501

ANNEX V LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS Preamble 1. For the purposes of this list: Salts is taken to mean: salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines; salts of the anions chloride, bromide, sulphate, acetate. Esters is taken to … 828 unchanged words … 7492-55-9, 7757-81-5, 24634-61-5 203-768-7, 231-321-6, 231-819-3, 246-376-1 0,6 % (acid) 5 Formal-dehyde, paraformaldehyde Formaldehyde Paraformaldehyde 50-00-0, 30525-89-4 200-001-8 Oral products 0,1 % (free formaldehyde) Not to be used in aerosol dispensers (sprays) Other products 0,2 % (free formaldehyde) 6 Moved or deleted 7 Biphenyl-2-ol Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl Sodium 2-biphenylate o-Phenylphenol Sodium o-Phenylphenate 90-43-7 132-27-4 201-993-5 205-055-6 (a) Rinse-off Products products (b) Leave-on products (a) 0,2 % (as phenol) Avoid contact with eyes (b) Leave-on products phenol (b) 0,15 % (as phenol) When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. Avoid contact with eyes 8 Pyrithione zinc Zinc pyrithione 13463-41-7 236-671-3 Hair products 1,0 % Only in rinse-off products Not to be used in oral products Other products 0,5 % 9 Inorganic sulphites and hydrogen- sulphites Sodium sulfite, ammonium bisulfite, ammonium sulfite, potassium sulfite, potassium hydrogen … 1,203 unchanged words … and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, silver(1+) salt, monohydrate Citric acid (and) Silver citrate — 460-890-5 0,2 %, corresponding to 0,0024 % of silver Not to be used in oral products and eye products 60 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one Hydroxyethoxyphenyl Butanone 569646-79-3 933-435-8 0,7 %